000 | 01252 a2200325 4500 | ||
---|---|---|---|
005 | 20250515232354.0 | ||
264 | 0 | _c20110301 | |
008 | 201103s 0 0 eng d | ||
022 | _a1996-3181 | ||
024 | 7 |
_a10.2174/187152710793361595 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWhite, Caitlin M | |
245 | 0 | 0 |
_aTherapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders. _h[electronic resource] |
260 |
_bCNS & neurological disorders drug targets _cNov 2010 |
||
300 |
_a661-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aNervous System Diseases _xdrug therapy |
650 | 0 | 4 |
_aReceptors, Vasoactive Intestinal Peptide _xdrug effects |
650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xmetabolism |
700 | 1 | _aJi, Sunggoan | |
700 | 1 | _aCai, Huan | |
700 | 1 | _aMaudsley, Stuart | |
700 | 1 | _aMartin, Bronwen | |
773 | 0 |
_tCNS & neurological disorders drug targets _gvol. 9 _gno. 5 _gp. 661-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/187152710793361595 _zAvailable from publisher's website |
999 |
_c19975645 _d19975645 |